Centers of Biomedical Research Excellence (COBRE) Phase 3

National Institutes of Health

Description

The COBRE Phase 3 grant aims to strengthen the research foundation established in earlier phases by continuing to support research and research infrastructure. It also focuses on implementing strategies to maintain high research standards even after the funding ends.

The purpose of the COBRE Phase 3 award is to solidify the research base built in Phases 1 and 2 through continued support of research and research infrastructure, and to implement strategies to sustain research excellence beyond COBRE funding.

Source

Grant ID

PAR-23-216

Agency

National Institutes of Health

Subcategory/Subagency

National Institute of General Medical Sciences

Program

SBIR

Key Dates

Opportunity Released

July 11, 2023

Open for Submission

July 11, 2023

Submission Deadline

September 30, 2025

Application Window Closes

September 30, 2025

Eligibility

The following categories of applicants are invited to apply:

  • U.S. recipient organizations with active COBRE Phase 2 Center awards (including those in a no-cost extension) on the application due date
Additional Eligibility Information
Organizational eligibility: - Only current recipient organizations holding COBRE Phase 2 Center awards that are active on the application due date (including those in a no-cost extension) may apply. - Foreign (non-U.S.) institutions are not eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Required registrations (must be completed/maintained prior to submissi…
Links
Similar opportunities

Save this grant and explore more opportunities

Share Grant

Share this grant opportunity with others.
Anyone with this link can view the grant details.